CD6-CAR Tregs Safety and Early Evidence of Therapeutic Effect in Patients with Chronic Graft-Versus-Host Disease

Key Points

• CD6-CAR Tregs demonstrate early signs of therapeutic effect in chronic graft-versus-host disease.
• Out of the assessed patients, a notable proportion experienced improved health metrics during treatment.
• The analysis leverages immunotherapy approaches to target chronic graft-versus-host disease effectively.
• The findings may encourage wider adoption of CD6-CAR Tregs but require further validation in larger cohorts.